nach oben

Erschienen in:

01.03.2009

HLA Class II (DRB, DQA1 and DQB1) Allele and Haplotype Frequencies in the Patients with Pemphigus Vulgaris

verfasst von: Sheida Shams, Ali Akbar Amirzargar, Maryam Yousefi, Nima Rezaei, Ghasem Solgi, Farideh Khosravi, Bita Ansaripour, Batoul Moradi, Behrouz Nikbin

Erschienen in: Journal of Clinical Immunology | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Pemphigus vulgaris (PV), an autoimmune disease affecting the skin and mucous membranes, is associated with some human leukocyte antigen (HLA) class II alleles and haplotypes.

Materials and Methods

In order to evaluate the association of HLA-DR and DQ alleles and haplotypes in Iranian non-Jewish patients with PV, 52 patients with PV and 180 normal subjects as control group were investigated in this study.

Results and Discussion

HLA-DRB1*04, -DRB1*1401, -DRB4, -DQA1*0104, -DQA1*03011, -DQB1*0302, and -DQB1*0502 alleles have been significantly increased in our patients group. Moreover, the haplotypes HLA-DRB1*04/-DQA1*03011/-DQB1*0302 and HLA-DRB1*1401/-DQA1*0104/-DQB1*0502 increased significantly in our patients. In contrast, the following alleles decreased significantly in our patients: HLA-DRB1*15, -DRB1*0301, -DRB1*07, -DRB1*11, -DRB5, -DQA1*0101, -DQA1*0103, -DQA1*201, -DQA1*05, -DQB1*0201, -DQB1*0301, -DQB1*06011, and -DQB1*0602. In addition, HLA-DRB1*15/-DQA1*0103/-DQB1*06011, HLA-DRB1*0301/-DQA1*05011/-DQB1*0201, HLA-DRB1*07/-DQA1*0201/-DQB1*0201, and HLA-DRB1*11/-DQA1*05/-DQB1*03011 decreased significantly in our patients. Genetic factors are involved in the occurrence of PV; HLA-DRB1*04 and -DRB1*1401 alleles and the related haplotypes are suggestive to be two major PV susceptibility factors in our population study.

Tron F, Gilbert D, Mouquet H, Joly P, Drouot L, Makni S, et al. Genetic factors in pemphigus. J Autoimmun 2005;24:319–28. doi:10.1016/j.jaut.2005.03.006.PubMedCrossRef

Loiseau P, Lecleach L, Prost C, Lepage V, Busson M, Bastuji-Garin S, et al. HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus. J Autoimmun 2000;15:67–73. doi:10.1006/jaut.2000.0388.PubMedCrossRef

Wucherpfennig KW, Yu B, Bhol K, Monos DS, Argyris E, Karr RW, et al. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci USA 1995;92:11935–9. doi:10.1073/pnas.92.25.11935.PubMedCrossRef

Lin MS, Swartz SJ, Lopez A, Ding X, Fernandez-Vina MA, Stastny P, et al. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest 1997;99:31–40. doi:10.1172/JCI119130.PubMedCrossRef

Veldman C, Stauber A, Wassmuth R, Uter W, Schuler G, Hertl M. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles. J Immunol 2003;170:635–42.PubMed

Hertl M, Veldman CM. T-cellular autoimmunity against desmogleins in pemphigus, an autoantibody-mediated bullous disorder of the skin. Autoimmun Rev 2003;2:278–83. doi:10.1016/S1568-9972(03)00035-1.PubMedCrossRef

Chams-Davatchi C, Valikhani M, Daneshpazhooh M, Esmaili N, Balighi K, Hallaji Z, et al. Pemphigus: analysis of 1209 cases. Int J Dermatol 2005;44:470–6. doi:10.1111/j.1365-4632.2004.02501.x.PubMedCrossRef

Scharf SJ, Friedmann A, Brautbar C, Szafer F, Steinman L, Horn G, et al. HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc Natl Acad Sci USA 1988;85:3504–8. doi:10.1073/pnas.85.10.3504.PubMedCrossRef

Scharf SJ, Freidmann A, Steinman L, Brautbar C, Erlich HA. Specific HLA-DQB and HLA-DRB1 alleles confer susceptibility to pemphigus vulgaris. Proc Natl Acad Sci USA 1989;86:6215–9. doi:10.1073/pnas.86.16.6215.PubMedCrossRef

10.

Birol A, Anadolu RY, Tutkak H, Gurgey E. HLA-class 1 and class 2 antigens in Turkish patients with pemphigus. Int J Dermatol 2002;41:79–83. doi:10.1046/j.1365-4362.2002.01370.x.PubMedCrossRef

11.

Ahmed AR, Wagner R, Khatri K, Notani G, Awdeh Z, Alper CA, et al. Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA 1991;88:5056–60. doi:10.1073/pnas.88.11.5056.PubMedCrossRef

12.

Loewenthal R, Slomov Y, Gonzalez-Escribano MF, Goldberg I, Korostishevsky M, Brenner S, et al. Common ancestral origin of pemphigus vulgaris in Jews and Spaniards: a study using microsatellite markers. Tissue Antigens 2004;63:326–34. doi:10.1111/j.0001-2815.2004.00191.x.PubMedCrossRef

13.

Riechers R, Grotzinger J, Hertl M. HLA class II restriction of autoreactive T cell responses in pemphigus vulgaris: review of the literature and potential applications for the development of a specific immunotherapy. Autoimmunity 1999;30:183–96.PubMedCrossRef

14.

Gazit E, Loewenthal R. The immunogenetics of pemphigus vulgaris. Autoimmun Rev 2005;4:16–20. doi:10.1016/j.autrev.2004.05.002.PubMedCrossRef

15.

Amirzargar AA, Yalda A, Hajabolbaghi M, Khosravi F, Jabbari H, Rezaei N, et al. The association of HLA-DRB, DQA1, DQB1 alleles and haplotype frequency in Iranian patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 2004;8:1017–21.PubMed

16.

Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225–35.PubMedCrossRef

17.

Amirzargar A, Mytilineos J, Farjadian S, Doroudchi M, Scherer S, Opelz G, et al. Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population. Hum Immunol 2001;62:1234–8. doi:10.1016/S0198-8859(01)00320-2.PubMedCrossRef

18.

Mobini N, Yunis EJ, Alper CA, Yunis JJ, Delgado JC, Yunis DE, et al. Identical MHC markers in non-Jewish Iranian and Ashkenazi Jewish patients with pemphigus vulgaris: possible common central Asian ancestral origin. Hum Immunol 1997;57:62–7. doi:10.1016/S0198-8859(97)00182-1.PubMedCrossRef

19.

Black M, Mignogna MD, Scully C, Number II. Pemphigus vulgaris. Oral Dis 2005;11:119–30.PubMed

20.

Ahmed AR, Mohimen A, Yunis EJ, Mirza NM, Kumar V, Beutner EH, et al. Linkage of pemphigus vulgaris antibody to the major histocompatibility complex in healthy relatives of patients. J Exp Med 1993;177:419–24. doi:10.1084/jem.177.2.419.PubMedCrossRef

21.

Bhol K, Yunis J, Ahmed AR. Pemphigus vulgaris in distant relatives of two families: association with major histocompatibility complex class II genes. Clin Exp Dermatol 1996;21:100–3. doi:10.1111/j.1365-2230.1996.tb00029.x.PubMedCrossRef

22.

Delgado JC, Hameed A, Yunis JJ, Bhol K, Rojas AI, Rehman SB, et al. Pemphigus vulgaris autoantibody response is linked to HLA-DQB1*0503 in Pakistani patients. Hum Immunol 1997;57:110–9. doi:10.1016/S0198-8859(97)00203-6.PubMedCrossRef

23.

Miyagawa S, Amagai M, Niizeki H, Yamashina Y, Kaneshige T, Nishikawa T, et al. HLA-DRB1 polymorphisms and autoimmune responses to desmogleins in Japanese patients with pemphigus. Tissue Antigens 1999;54:333–40. doi:10.1034/j.1399-0039.1999.540402.x.PubMedCrossRef

24.

Geng L, Wang Y, Zhai N, Lu YN, Song FJ, Chen HD. Association between pemphigus vulgaris and human leukocyte antigen in Han nation of northeast China. Chin Med Sci J 2005;20:166–70.PubMed

25.

Glorio R, Rodriguez Costa G, Haas R, Gruber M, Fainboim L, Woscoff A. HLA haplotypes and class II molecular alleles in Argentinian patients with pemphigus vulgaris. J Cutan Med Surg 2002;6:422–6. doi:10.1007/s10227-001-0157-z.PubMedCrossRef

26.

Slomov E, Loewenthal R, Goldberg I, Korostishevsky M, Brenner S, Gazit E. Pemphigus vulgaris in Jewish patients is associated with HLA-A region genes: mapping by microsatellite markers. Hum Immunol 2003;64:771–9. doi:10.1016/S0198-8859(03)00092-2.PubMedCrossRef

Titel: HLA Class II (DRB, DQA1 and DQB1) Allele and Haplotype Frequencies in the Patients with Pemphigus Vulgaris
verfasst von: Sheida Shams
Ali Akbar Amirzargar
Maryam Yousefi
Nima Rezaei
Ghasem Solgi
Farideh Khosravi
Bita Ansaripour
Batoul Moradi
Behrouz Nikbin
Publikationsdatum: 01.03.2009
Verlag: Springer US
Erschienen in: Journal of Clinical Immunology / Ausgabe 2/2009
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-008-9244-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

HLA Class II (DRB, DQA1 and DQB1) Allele and Haplotype Frequencies in the Patients with Pemphigus Vulgaris

Abstract

Introduction

Materials and Methods

Results and Discussion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Introduction

Materials and Methods

Results and Discussion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2009

5′ Regulatory and 3′ Untranslated Region Polymorphisms of Vitamin D Receptor Gene in South Indian HIV and HIV–TB Patients

Clinical Significance of Serum HMGB-1 and sRAGE Levels in Systemic Sclerosis: Association with Disease Severity

Functionally Diverse Subsets in CD4 T Cell Responses Against Influenza

Human Immune Memory to Yellow Fever and Smallpox Vaccination

First Report of Clinical, Functional, and Molecular Investigation of Chronic Granulomatous Disease in Nine Jordanian Families

Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin